Baronsmead Venture Trust PLC (BVT) has disclosed that Non-Executive Director Michael Probin purchased 8,626 ordinary shares on 19 November 2026, at a price of 46.37 pence per share, via the London Stock Exchange. The transaction was conducted under the Prospectus for Offers for Subscription issued in October 2026, marking Probin's initial notification as a person discharging managerial responsibilities. Director share purchases are closely watched by investors as a signal of insider confidence in a company's prospects and valuation.
Key Points
- Baronsmead Venture Trust PLC (BVT) — a UK-listed venture capital trust managed by Gresham House
- Non-Executive Director Michael Probin purchased 8,626 ordinary shares on 19 November 2026 at 46.37 pence each
- The purchase was made under the October 2026 Prospectus for Offers for Subscription; shares carry an ISIN of GB0002631934
- Investors may be watching whether further PDMR purchases follow under the same October 2026 prospectus offer
Michael Probin's Share Purchase Under the October 2026 Baronsmead Prospectus Offer
The announcement states that Michael Probin, serving as a Non-Executive Director of Baronsmead Venture Trust PLC, acquired 8,626 ordinary shares of £0.10 each at a price of 0.4637 GBP per share on 19 November 2026. The transaction was recorded as a single purchase executed on the London Stock Exchange and was made specifically under the Prospectus for Offers for Subscription that the company issued in October 2026. The disclosure was filed as an initial notification under regulatory requirements governing persons discharging managerial responsibilities and their closely associated persons.
Baronsmead Venture Trust and Its Role as a UK Venture Capital Trust
Baronsmead Venture Trust PLC is a long-established UK venture capital trust, investing primarily in smaller, growth-focused British companies. The trust is managed by Gresham House, a specialist alternative asset manager, and investor relations are handled through the Gresham House team in London. As a VCT, Baronsmead raises capital from retail investors via prospectus offers, deploying funds into qualifying early-stage and development-stage businesses. VCTs operate within a specific UK tax-advantaged framework, meaning the structure of its share offers — such as the October 2026 prospectus referenced in this announcement — carries particular regulatory significance for qualifying shareholders.
Regulatory Context of PDMR Notifications for BVT Shareholders
Under UK market abuse regulations, directors and other PDMRs are required to notify both the company and the Financial Conduct Authority of transactions in the issuer's securities within a defined timeframe. This disclosure by Probin fulfils that obligation, confirming the purchase took place on 19 November 2026 on the London Stock Exchange under identifier XLON. The ordinary shares in question carry the ISIN GB0002631934. Such notifications provide transparency to the wider market regarding insider activity and form part of the governance framework applicable to all UK-listed investment trusts, including those structured as venture capital trusts.




Please wait processing your request...